Well it seems as though the rumors we have heard about Medtronic selling their diabetes franchise to a private equity group are true. While the terms of the transaction are still not final and as with all deals until the ink is dry nothing is set in concrete. Here is what we know so far:
1. Aloha Capital Management is the lead private equity group. We endeavored to reach out to Aloha as quite honestly no one we reached out to knew much about them.
2. The purchase price is a whopping $6 Billion although we aren’t certain if . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.